BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19524126)

  • 1. Characterization of promoter elements required for cardiac chamber-specific expression.
    Majalahti T; Tokola H; Ruskoaho H; Vuolteenaho O
    Mol Cell Endocrinol; 2009 Aug; 307(1-2):50-6. PubMed ID: 19524126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the human brain natriuretic peptide gene by GATA-4.
    He Q; Mendez M; LaPointe MC
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E50-7. PubMed ID: 12067842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac BNP gene activation by angiotensin II in vivo.
    Majalahti T; Suo-Palosaari M; Sármán B; Hautala N; Pikkarainen S; Tokola H; Vuolteenaho O; Wang J; Paradis P; Nemer M; Ruskoaho H
    Mol Cell Endocrinol; 2007 Jul; 273(1-2):59-67. PubMed ID: 17587490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes.
    Pikkarainen S; Kerkelä R; Pöntinen J; Majalahti-Palviainen T; Tokola H; Eskelinen S; Vuolteenaho O; Ruskoaho H
    J Mol Med (Berl); 2002 Jan; 80(1):51-60. PubMed ID: 11862325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression.
    Majalahti-Palviainen T; Hirvinen M; Tervonen V; Ilves M; Ruskoaho H; Vuolteenaho O
    Endocrinology; 2000 Feb; 141(2):731-40. PubMed ID: 10650955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical load-induced alterations in B-type natriuretic peptide gene expression.
    Tokola H; Hautala N; Marttila M; Magga J; Pikkarainen S; Kerkelä R; Vuolteenaho O; Ruskoaho H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):646-53. PubMed ID: 11558673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription.
    McBride K; Nemer M
    Can J Physiol Pharmacol; 2001 Aug; 79(8):673-81. PubMed ID: 11558676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 responsiveness of a 1.4 kb phospholamban promoter fragment in rat cardiomyocytes transfected by the gene gun.
    Eizema K; van Heugten HA; Bezstarosti K; van Setten MC; Lamers JM
    J Mol Cell Cardiol; 2000 Feb; 32(2):311-21. PubMed ID: 10722806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Sp1 binding sequences in basal transcription of the rat fibroblast growth factor-2 gene in neonatal cardiomyocytes.
    Tang W; Pan Q; Sun F; Ma J; Tang S; Le K; Wan Y; Chen Q; Liu P
    Life Sci; 2009 Mar; 84(13-14):421-7. PubMed ID: 19302822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
    Seyed M; Dimario JX
    J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes.
    Bingham AJ; Ooi L; Kozera L; White E; Wood IC
    Mol Cell Biol; 2007 Jun; 27(11):4082-92. PubMed ID: 17371849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of inducible brain natriuretic peptide promoter activity.
    Ma KK; Banas K; de Bold AJ
    Regul Pept; 2005 Jun; 128(3):169-76. PubMed ID: 15837525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA4 mediates activation of the B-type natriuretic peptide gene expression in response to hemodynamic stress.
    Marttila M; Hautala N; Paradis P; Toth M; Vuolteenaho O; Nemer M; Ruskoaho H
    Endocrinology; 2001 Nov; 142(11):4693-700. PubMed ID: 11606434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the cardiac KCNE1 gene promoter.
    Mustapha Z; Pang L; Nattel S
    Cardiovasc Res; 2007 Jan; 73(1):82-91. PubMed ID: 17141204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors.
    Klapper M; Böhme M; Nitz I; Döring F
    Hum Mutat; 2008 Jan; 29(1):142-9. PubMed ID: 17960769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a ventricle-specific promoter for the zebrafish ventricular myosin heavy chain (vmhc) gene and its regulation by GATA factors during embryonic heart development.
    Park JS; Kim HS; Kim JD; Seo J; Chung KS; Lee HS; Huh TL; Jo I; Kim YO
    Dev Dyn; 2009 Jun; 238(6):1574-81. PubMed ID: 19441085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of the brain natriuretic peptide gene.
    LaPointe MC
    Peptides; 2005 Jun; 26(6):944-56. PubMed ID: 15911064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4, a new regulator of cardiac fibroblasts, is sensitive to natriuretic peptides.
    Jankowski M
    Cardiovasc Res; 2009 Nov; 84(2):176-7. PubMed ID: 19713284
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of salmon cardiac peptide (sCP) in the heart of salmon (Salmo salar L.).
    Arjamaa O; Sormunen R; Lehto VP; Vuolteenaho O
    Gen Comp Endocrinol; 2000 Dec; 120(3):276-82. PubMed ID: 11121292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.